Rouba Garro, MD
Pediatric Nephrology · Atlanta, GANPI 1427380542
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,895 of the $9,147 with a category attached, or 64.4%. Amgen accounts for 72.1% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $6,633 and has fallen 66.2% since, to $2,240 in 2025.
Across 29 payments — averaging $315.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$7K
- Merck$2K
- AstraZeneca$813
- Alnylam Pharmaceuticals Inc.$105
- Takeda Pharmaceuticals U.S.A., Inc.$40
- Novartis$21
- plus $5 from 1 others
What the payments were for
- Consulting fees$5,89564%
- Travel & lodging$2,28825%
- Food & beverage$95910%
- Education$50%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 11 | $6,593 |
| Merck | 10 | $1,570 |
| AstraZeneca | 3 | $813 |
| Alnylam Pharmaceuticals Inc. | 1 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $40 |
| Novartis | 1 | $21 |
| Travere Therapeutics, Inc. | 2 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric nephrology providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Calcitriol | 28 | $340 |
| Prednisone | 39 | $153 |
| Pravastatin Sodium | 14 | $65 |
| Losartan Potassium | 17 | $21 |
| Amlodipine Besylate | 20 | $10 |
Paid to pharmacies, not to this prescriber.
Other pediatric nephrology in Atlanta
- Laurence GreenbaumAtlanta$164K
- Sabina KennedyAtlanta$175
- Jacob HumphreyAtlanta$119
- Pamela WinterbergAtlanta$74
- Chia-Shi WangAtlanta$4
- Barry WarshawAtlanta$4
- Stephanie JerniganAtlanta$4
- Asifhusen MansuriAugusta$1K
- Luis OrtizAugusta$948
- Heather StewartSavannah$579
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.